Skip to main content

Table 2 Study Characteristics

From: Deflazacort for the treatment of Duchenne Dystrophy: A systematic review

Study No. Author (s) Year Source Publication Status Inclusion Criteria Met Reason for Exclusion
A Bonifati et al. [19] 2000 Muscle and Nerve Article Yes -
B Angelini et al. [20] 1994 Muscle and Nerve Article Yes -
C Mesa et al. [21] 1991 Neuromuscular Disorders Article No Not randomized.
D Reitter [22] 1995 Brain and Development Article No Interim report of a trial. No results by treatment given.
E Luz et al. [23] 1982 Revista Chilena de Pediatria Article No Not randomized.
F Angelini et al. [24] 1998 Muscle and Nerve Abstract Yes -
G Angelini et al. [25] 1995 Neurology Abstract Yes -
H Reitter [26] 1995 Developmental Medicine and Child Neurology Abstract No Interim report of a trial. No results by treatment given.
I Winter et al. [27] 1999 Acta Myologica Article No No strength or side effect data reported.
J Rietter [28] 1995 Monatsschrift fur Kinderheilkunde N/A N/A Not retrieved. Felt to be a duplicate publication.
K Todorovic et al. [29] 1998 Muscle and Nerve Abstract No DFZ not used.
L Reitter [13] 1998 Neuromuscular Disorders Meeting Proceeding No Report of randomized trial but no specific outcomes reported.
M Dubrovsky et al. [30] 1999 Neurology Abstract No Not randomized
N Brooke [12] 1996 Neurology Abstract Yes -
O ENMC Workshop [31] 1997 Neuromuscular Disorders Meeting Proceeding No Report of randomized trial but no specific outcomes reported.
  1. ENMC = European Neuromuscular Centre